Singapore markets closed

Marpai, Inc. (MRAI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.3300-0.1500 (-6.05%)
At close: 04:00PM EDT
2.3800 +0.05 (+2.15%)
After hours: 04:26PM EDT

Marpai, Inc.

401 Park Avenue South
Floor 10
New York, NY 10016
United States
855 389 7330

IndustryHealthcare Plans
Full-time employees162

Key executives

NameTitlePayExercisedYear born
Mr. Damien Francis LamendolaCEO & DirectorN/AN/A1957
Mr. Steve JohnsonCFO & Company SecretaryN/AN/A1971
Mr. John PowersPresident & COON/AN/A1968
Dr. Eli DavidCo-Founder & Chief Science AdvisorN/AN/A1982
Ms. Pamela BurnsVice President of Enterprise SalesN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.

Corporate governance

Marpai, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.